Literature DB >> 15811787

Applying instance-based techniques to prediction of final outcome in acute stroke.

Christian Gottrup1, Knud Thomsen, Peter Locht, Ona Wu, A Gregory Sorensen, Walter J Koroshetz, Leif Østergaard.   

Abstract

OBJECTIVE: Acute cerebral stroke is a frequent cause of death and the major cause of adult neurological disability in the western world. Thrombolysis is the only established treatment of ischemic stroke; however, its use carries a substantial risk of symptomatic intracerebral hemorrhage. A clinical tool to guide the use of thrombolysis would be very valuable. One of the major goals of such a tool would be the identification of potentially salvageable tissue. This requires an accurate prediction of the extent of infarction if untreated. In this study, we investigate the applicability of highly flexible instance-based (IB) methods for such predictions. METHODS AND MATERIALS: Based on information obtained from magnetic resonance imaging of 14 patients with acute stroke, we explored three different implementations of the IB method: k-NN, Gaussian weighted, and constant radius search classification. Receiver operating characteristics analysis, in particular area under the curve (AUC), was used as performance measure.
RESULTS: We found no significant difference (P = 0.48) in performance for the optimal k-NN (k = 164, AUC = 0.814 +/- 0.001) and Gaussian weight (sigma = 0.17, AUC = 0.813 +/- 0.001) implementations, while they were both significantly better (P < 1 x 10(-6) for both) than the constant radius implementation (R = 0.28, AUC = 0.809 +/- 0.001). Qualitative analyses of the distribution of instances in the feature space indicated that non-infarcted instances tends to cluster together while infarcted instances are more dispersed, and that there may not exist a stringent boundary separating infarcted from non-infarcted instances.
CONCLUSIONS: This study shows that IB methods can be used, and may be advantageous, for predicting final infarct in patients with acute stroke, but further work must be done to make them clinically applicable.

Entities:  

Mesh:

Year:  2005        PMID: 15811787     DOI: 10.1016/j.artmed.2004.06.003

Source DB:  PubMed          Journal:  Artif Intell Med        ISSN: 0933-3657            Impact factor:   5.326


  7 in total

1.  Multiparametric magnetic resonance imaging of brain disorders.

Authors:  Ona Wu; Rick M Dijkhuizen; Alma Gregory Sorensen
Journal:  Top Magn Reson Imaging       Date:  2010-04

2.  Learning Instance-Specific Predictive Models.

Authors:  Shyam Visweswaran; Gregory F Cooper
Journal:  J Mach Learn Res       Date:  2010-12-01       Impact factor: 3.654

3.  Decision path models for patient-specific modeling of patient outcomes.

Authors:  Antonio Ferreira; Gregory F Cooper; Shyam Visweswaran
Journal:  AMIA Annu Symp Proc       Date:  2013-11-16

4.  Supervised pattern recognition for the prediction of contrast-enhancement appearance in brain tumors from multivariate magnetic resonance imaging and spectroscopy.

Authors:  Michael C Lee; Sarah J Nelson
Journal:  Artif Intell Med       Date:  2008-04-29       Impact factor: 5.326

5.  Early identification of potentially salvageable tissue with MRI-based predictive algorithms after experimental ischemic stroke.

Authors:  Mark J R J Bouts; Ivo A C W Tiebosch; Annette van der Toorn; Max A Viergever; Ona Wu; Rick M Dijkhuizen
Journal:  J Cereb Blood Flow Metab       Date:  2013-04-10       Impact factor: 6.200

6.  Multiclass Support Vector Machine-Based Lesion Mapping Predicts Functional Outcome in Ischemic Stroke Patients.

Authors:  Nils Daniel Forkert; Tobias Verleger; Bastian Cheng; Götz Thomalla; Claus C Hilgetag; Jens Fiehler
Journal:  PLoS One       Date:  2015-06-22       Impact factor: 3.240

7.  Performance of Machine Learning for Tissue Outcome Prediction in Acute Ischemic Stroke: A Systematic Review and Meta-Analysis.

Authors:  Xinrui Wang; Yiming Fan; Nan Zhang; Jing Li; Yang Duan; Benqiang Yang
Journal:  Front Neurol       Date:  2022-07-08       Impact factor: 4.086

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.